Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase A02.012: retropepsin (human T-cell leukemia virus)

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates

(Topics flags: S Structure, A Assay, T Target, P Specificity, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Awahara,C., Oku,D., Furuta,S., Kobayashi,K., Teruya,K., Akaji,K. and Hattori,Y.
    Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. Molecules 2022, 27, 1646
    Molecules (2025) 30 PubMed  Europe PubMed DOI  PMC  EPMC
    2. 2024
  2. Akash,S., Sultana,S., Islam,M.N., Or Rashid,M.H., Oduselu,G.O., Kaouche,F.C., Sindi,E.R., de Farias Morais,G.C., Al-Dies,A.M. and Oliveira,J.I.N.
    Discovery of Galangin Derivatives as a Potential T-cell Leukemia Virus 1 Protease Inhibitor Through Chemoinformatics Approaches
    Cell Biochem Biophys (2024) PubMed  Europe PubMed DOI
  3. Awahara,C., Oku,D., Kobayashi,K. and Hattori,Y.
    Evaluating a Retro-Inverso Type Inhibitor of HTLV-1 Protease as a Competitive Inhibitor
    Chem Pharm Bull (Tokyo) (2024) 72, 309-310. PubMed  Europe PubMed DOI
    4. 2023
  4. Ahmadi Ghezeldasht,S., Momen Heravi,M., Valizadeh,N., Rafatpanah,H., Shamsian,S.A., Mosavat,A. and Rezaee,S.A.
    Development of a Novel HTLV-1 Protease: Human Fcgamma1 Recombinant Fusion Molecule in the CHO Eukaryotic Expression System
    Appl Biochem Biotechnol (2023) 195, 1862-1876. PubMed  Europe PubMed DOI  PMC  EPMC
    5. 2022
  5. Awahara,C., Oku,D., Furuta,S., Kobayashi,K., Teruya,K., Akaji,K. and Hattori,Y.
    The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
    Molecules (2022) 27 PubMed  Europe PubMed DOI  PMC  EPMC
    6. 2021
  6. Kassay,N., Motyan,J.A., Matuz,K., Golda,M. and Tozser,J.
    Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases
    Life (Basel) (2021) 11 PubMed  Europe PubMed DOI  PMC  EPMC  I
  7. Lockbaum,G.J., Henes,M., Talledge,N., Rusere,L.N., Kosovrasti,K., Nalivaika,E.A., Somasundaran,M., Ali,A., Mansky,L.M., Kurt Yilmaz,N. and Schiffer,C.A.
    Inhibiting HTLV-1 Protease: A Viable Antiviral Target
    ACS Chem Biol (2021) 16, 529-538. PubMed  Europe PubMed DOI  I
    8. 2019
  8. Mirhosseini,A., Mohareri,M., Arab,R., Rezaee,S.A., Shirdel,A., Koshyar,M.M., Allahyari,A., Bari,A., Rahimi,H., Mozaheb,Z., Bazarbachi,A., Boostani,R., Mashkani,B. and Rafatpanah,H.
    Complete sequence of human T cell leukemia virus type 1 in ATLL patients from Northeast Iran, Mashhad revealed a prematurely terminated protease and an elongated pX open reading frame III
    Infect Genet Evol (2019) 73, 460-469. PubMed  Europe PubMed DOI
    9. 2016
  9. Kheirabadi,M., Maleki,J., Soufian,S. and Hosseini,S.
    Design of new potent HTLV-1 protease inhibitors: in silico study
    Mol Biol Res Commun (2016) 5, 19-30. PubMed  Europe PubMed  PMC  EPMC  I
    10. 2015
  10. Ma,S., Vogt,K.A., Petrillo,N. and Ruhoff,A.J.
    Characterizing the protonation states of the catalytic residues in apo and substrate-bound human T-cell leukemia virus type 1 protease
    Comput Biol Chem (2015) 56, 61-70. PubMed  Europe PubMed DOI
  11. Selvaraj,C., Omer,A., Singh,P. and Singh,S.K.
    Molecular insights of protein contour recognition with ligand pharmacophoric sites through combinatorial library design and MD simulation in validating HTLV-1 PR inhibitors
    Mol Biosyst (2015) 11, 178-189. PubMed  Europe PubMed DOI  I
    12. 2014
  12. Awahara,C., Tatsumi,T., Furuta,S., Shinjoh,G., Konno,H., Nosaka,K., Kobayashi,K., Hattori,Y. and Akaji,K.
    Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor
    Bioorg Med Chem (2014) 22, 2482-2488. PubMed  Europe PubMed DOI  I
  13. Selvaraj,C., Singh,P. and Singh,S.K.
    Molecular modeling studies and comparative analysis on structurally similar HTLV and HIV protease using HIV-PR inhibitors
    J Recept Signal Transduct Res (2014) 34, 361-371. PubMed  Europe PubMed DOI  I
    14. 2012
  14. Demir,A., Oguariri,R.M., Magis,A., Ostrov,D.A., Imamichi,T. and Dunn,B.M.
    Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cells
    Antivir Ther (2012) 17, 883-892. PubMed  Europe PubMed DOI  I
  15. Nguyen,J.T. and Kiso,Y.
    Human T-cell leukemia virus type I (HTLV-I) retropepsin
    [ISSN:978-0-12-407744-7] (2012) 3, 213-217. DOI
    16. 2011
  16. Kumada,H.O., Nguyen,J.T., Kakizawa,T., Hidaka,K., Kimura,T., Hayashi,Y. and Kiso,Y.
    Development of [Ile41]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate
    J Pept Sci (2011) 17, 569-575. PubMed  Europe PubMed DOI  A
  17. Nguyen,J.T., Kato,K., Kumada,H.O., Hidaka,K., Kimura,T. and Kiso,Y.
    Maintaining potent HTLV-I protease inhibition without the P3-cap moiety in small tetrapeptidic inhibitors
    Bioorg Med Chem Lett (2011) 21, 1832-1837. PubMed  Europe PubMed DOI  I
  18. Nguyen,J.T., Kato,K., Hidaka,K., Kumada,H.O., Kimura,T. and Kiso,Y.
    Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles
    Bioorg Med Chem Lett (2011) 21, 2425-2429. PubMed  Europe PubMed DOI  I
  19. Rucker,P., Horn,A.H.C., Meiselbach,H. and Sticht,H.
    A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network
    J Mol Model (2011) 17, 2693-2705. PubMed  Europe PubMed DOI
    20. 2010
  20. Li,C., Li,X. and Lu,W.
    Total chemical synthesis of human T-cell leukemia virus type 1 protease via native chemical ligation
    Biopolymers (2010) 94, 487-494. PubMed  Europe PubMed DOI
  21. Satoh,T., Li,M., Nguyen,J.T., Kiso,Y., Gustchina,A. and Wlodawer,A.
    Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease
    J Mol Biol (2010) 401, 626-641. PubMed  Europe PubMed DOI  S  I
  22. Tatsumi,T., Awahara,C., Naka,H., Aimoto,S., Konno,H., Nosaka,K. and Akaji,K.
    Evaluation of retro-inverso modifications of HTLV-1 protease inhibitors containing a hydroxyethylamine isoster
    Bioorg Med Chem (2010) 18, 2720-2727. PubMed  Europe PubMed DOI  I
    23. 2009
  23. Kontijevskis,A., Petrovska,R., Yahorava,S., Komorowski,J. and Wikberg,J.E.
    Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates
    Bioorg Med Chem (2009) 17, 5229-5237. PubMed  Europe PubMed DOI  V  I
    24. 2008
  24. Eizert,H., Bander,P., Bagossi,P., Sperka,T., Miklossy,G., Boross,P., Weber,I.T. and Tozser,J.
    Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site
    J Virol (2008) 82, 10111-10117. PubMed  Europe PubMed DOI  PMC  EPMC  P
  25. Kadas,J., Boross,P., Weber,I.T., Bagossi,P., Matuz,K. and Tozser,J.
    C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity
    Biochem J (2008) 416, 357-364. PubMed  Europe PubMed DOI  PMC  EPMC
  26. Nguyen,J.T., Zhang,M., Kumada,H.O., Itami,A., Nishiyama,K., Kimura,T., Cheng,M., Hayashi,Y. and Kiso,Y.
    Truncation and non-natural amino acid substitution studies on HTLV-I protease hexapeptidic inhibitors
    Bioorg Med Chem Lett (2008) 18, 366-370. PubMed  Europe PubMed DOI  I
  27. Zhang,M., Nguyen,J.T., Kumada,H.O., Kimura,T., Cheng,M., Hayashi,Y. and Kiso,Y.
    Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties
    Bioorg Med Chem (2008) 16, 5795-5802. PubMed  Europe PubMed DOI  I
  28. Zhang,M., Nguyen,J.T., Kumada,H.O., Kimura,T., Cheng,M., Hayashi,Y. and Kiso,Y.
    Locking the two ends of tetrapeptidic HTLV-I protease inhibitors inside the enzyme
    Bioorg Med Chem (2008) 16, 6880-6890. PubMed  Europe PubMed DOI  I
    29. 2007
  29. Bang,J.K., Teruya,K., Aimoto,S., Konno,H., Nosaka,K., Tatsumi,T. and Akaji,K.
    Studies on substrate specificity at PR/p3 cleavage site of HTLV-1 protease
    Int J Pept Res Ther (2007) 13, 173-179. DOI  P
  30. Kimura,T., Nguyen,J.T., Maegawa,H., Nishiyama,K., Arii,Y., Matsui,Y., Hayashi,Y. and Kiso,Y.
    Chipping at large, potent human T-cell leukemia virus type 1 protease inhibitors to uncover smaller, equipotent inhibitors
    Bioorg Med Chem Lett (2007) 17, 3276-3280. PubMed  Europe PubMed DOI  I
  31. Tozser,J. and Weber,I.T.
    The protease of human T-cell leukemia virus type-1 is a potential therapeutic target
    Curr Pharm Des (2007) 13, 1285-1294. PubMed  Europe PubMed DOI  T
    32. 2006
  32. [YEAR:6-5-2006]Naka,H., Teruya,K., Bang,J.K., Aimoto,S., Tatsumi,T., Konno,H., Nosaka,K. and Akaji,K.
    Evaluations of substrate specificity and inhibition at PR/p3 cleavage site of HTLV-1 protease
    Bioorg Med Chem Lett (6-5-2006) 16, 3761-3764. PubMed  Europe PubMed DOI  I
    33. 2005
  33. Bagossi,P., Sperka,T., Feher,A., Kadas,J., Zahuczky,G., Miklossy,G., Boross,P. and Tozser,J.
    Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites
    J Virol (2005) 79, 4213-4218. PubMed  Europe PubMed DOI  PMC  EPMC  P
  34. [YEAR:20-12-2005]Li,M., Laco,G.S., Jaskolski,M., Rozycki,J., Alexandratos,J., Wlodawer,A. and Gustchina,A.
    Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design
    Proc Natl Acad Sci U S A (20-12-2005) 102, 18332-18337. PubMed  Europe PubMed DOI  PMC  EPMC  S
    35. 2004
  35. Abdel-Rahman,H.M., Kimura,T., Hidaka,K., Kiso,A., Nezami,A., Freire,E., Hayashi,Y. and Kiso,Y.
    Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases
    Biol Chem (2004) 385, 1035-1039. PubMed  Europe PubMed DOI
  36. Bagossi,P., Kadas,J., Miklossy,G., Boross,P., Weber,I.T. and Tozser,J.
    Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases
    J Virol Methods (2004) 119, 87-93. PubMed  Europe PubMed DOI  A  I
  37. Daenke,S.
    Human T-cell leukemia virus type I (HTLV-I) retropepsin
    [ISSN:0-12-079610-4] (2004) 2, 166-169.  V
  38. [YEAR:6-8-2004]Herger,B.E., Mariani,V.L., Dennison,K. and Shuker,S.B.
    The 10 C-terminal residues of HTLV-I protease are not necessary for enzymatic activity
    Biochem Biophys Res Commun (6-8-2004) 320, 1306-1308. PubMed  Europe PubMed DOI
  39. [YEAR:20-4-2004]Kadas,J., Weber,I.T., Bagossi,P., Miklossy,G., Boross,P., Oroszlan,S. and Tozser,J.
    Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease
    J Biol Chem (20-4-2004) 279, 27148-27157. PubMed  Europe PubMed DOI  I
  40. [YEAR:6-12-2004]Maegawa,H., Kimura,T., Arii,Y., Matsui,Y., Kasai,S., Hayashi,Y. and Kiso,Y.
    Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic
    Bioorg Med Chem Lett (6-12-2004) 14, 5925-5929. PubMed  Europe PubMed DOI  I
    41. 2003
  41. [YEAR:13-6-2003]Akaji,K., Teruya,K. and Aimoto,S.
    Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere
    J Org Chem (13-6-2003) 68, 4755-4763. PubMed  Europe PubMed DOI  I
  42. Davis,D.A., Brown,C.A., Newcomb,F.M., Boja,E.S., Fales,H.M., Kaufman,J., Stahl,S.J., Wingfield,P. and Yarchoan,R.
    Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation
    J Virol (2003) 77, 3319-3325. PubMed  Europe PubMed DOI  PMC  EPMC
  43. [YEAR:10-1-2003]Mariani,V.L. and Shuker,S.B.
    Identification of the RT-RH/IN cleavage site of HTLV-I
    Biochem Biophys Res Commun (10-1-2003) 300, 268-270. PubMed  Europe PubMed DOI  I
  44. Shuker,S.B., Mariani,V.L., Herger,B.E. and Dennison,K.J.
    Understanding HTLV-I protease
    Chem Biol (2003) 10, 373-380. PubMed  Europe PubMed DOI  I
    45. 2002
  45. Ha,J.J., Gaul,D.A., Mariani,V.L., Ding,Y.S., Ikeda,R.A. and Shuker,S.B.
    HTLV-I protease cleavage of P19/24 substrates is not dependent on NaCl concentration
    Bioorg Chem (2002) 30, 138-144. PubMed  Europe PubMed DOI  A
  46. [YEAR:18-2-2002]Teruya,K., Kawakami,T., Akaji,K. and Aimoto,S.
    Total synthesis of [L40I, C90A, C109A]-human T-cell leukemia virus type 1 protease
    Tetrahedron Lett (18-2-2002) 43, 1487-1490.
    47. 2000
  47. [YEAR:15-5-2000]Snasel,J., Shoeman,R., Horejsi,M., Hruskova-Heidingsfeldova,O., Sedlacek,J., Ruml,T. and Pichova,I.
    Cleavage of vimentin by different retroviral proteases
    Arch Biochem Biophys (15-5-2000) 377, 241-245. PubMed  Europe PubMed DOI
  48. Tozser,J., Zahuczky,G., Bagossi,P., Louis,J.M., Copeland,T.D., Oroszlan,S., Harrison,R.W. and Weber,I.T.
    Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases
    Eur J Biochem (2000) 267, 6287-6295. PubMed  Europe PubMed DOI
  49. [YEAR:16-3-2000]Zahuczky,G., Boross,P., Bagossi,P., Emri,G., Copeland,T.D., Oroszlan,S., Louis,J.M. and Tozser,J.
    Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase
    Biochim Biophys Acta (16-3-2000) 1478, 1-8. PubMed  Europe PubMed DOI  E
    50. 1999
  50. Boross,P., Bagossi,P., Copeland,T.D., Oroszlan,S., Louis,J.M. and Tozser,J.
    Effect of substrate residues on the P2 ' preference of retroviral proteinases
    Eur J Biochem (1999) 264, 921-929. PubMed  Europe PubMed DOI
  51. [YEAR:5-3-1999]Louis,J.M., Oroszlan,S. and Tozser,J.
    Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase
    J Biol Chem (5-3-1999) 274, 6660-6666. PubMed  Europe PubMed DOI
    52. 1998
  52. [YEAR:15-12-1998]Ding,Y.S., Rich,D.H. and Ikeda,R.A.
    Substrates and inhibitors of human T-cell leukemia virus type I protease
    Biochemistry (15-12-1998) 37, 17514-17518. PubMed  Europe PubMed DOI  I
  53. Ding,Y.S., Owen,S.M., Lal,R.B. and Ikeda,R.A.
    Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease
    J Virol (1998) 72, 3383-3386. PubMed  Europe PubMed  PMC  EPMC
    54. 1997
  54. Hruskova-Heidingsfeldova,O., Blaha,I., Urban,J., Strop,P. and Pichova,I.
    Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase
    Leukemia (1997) 11 Suppl 3, 45-46. PubMed  Europe PubMed
  55. Mamoun,R.Z., Dye,D., Rebeyrotte,N., Bouamr,F., Cerutti,M. and Desgranges,C.
    Mouse monoclonal antibodies directed against the HTLV-I protease recognize epitopes internal to the dimer
    J Acquir Immune Defic Syndr Hum Retrovirol (1997) 14, 184-188. PubMed  Europe PubMed
    56. 1995
  56. Hruskova-Heidingsfeldova,O.
    Proteins of bovine leukemia virus and human T-cell leukemia viruses
    Folia Biol (Praha) (1995) 41, 201-212. PubMed  Europe PubMed
    57. 1994
  57. Daenke,S., Schramm,H.J. and Bangham,C.R.
    Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding
    J Gen Virol (1994) 75, 2233-2239. PubMed  Europe PubMed
    58. 1993
  58. Saiga,A., Tanaka,T., Orita,S., Sato,A., Sato,S., Hachisu,T., Abe,K., Kimura,Y., Kondo,Y., Fujiwara,T. and Igarashi,H.
    Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity
    Arch Virol (1993) 128, 195-210. PubMed  Europe PubMed DOI
    59. 1992
  59. [YEAR:15-6-1992]Hayakawa,T., Misumi,Y., Kobayashi,M., Yamamoto,Y. and Fujisawa,Y.
    Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease
    Eur J Biochem (15-6-1992) 206, 919-925. PubMed  Europe PubMed DOI
    60. 1991
  60. [YEAR:31-12-1991]Hayakawa,T., Misumi,Y., Kobayashi,M., Ohi,Y., Fujisawa,Y., Kakinuma,A. and Hatanaka,M.
    Expression of human T-cell leukemia virus type I protease in Escherichia coli
    Biochem Biophys Res Commun (31-12-1991) 181, 1281-1287. PubMed  Europe PubMed
  61. Kobayashi,M., Ohi,Y., Asano,T., Hayakawa,T., Kato,K., Kakinuma,A. and Hatanaka,M.
    Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli
    FEBS Lett (1991) 293, 106-110. PubMed  Europe PubMed DOI
  62. Pettit,S.C., Simsic,J., Loeb,D.D., Everitt,L., Hutchison,C.A., III and Swanstrom,R.
    Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid
    J Biol Chem (1991) 266, 14539-14547. PubMed  Europe PubMed
    63. 1989
  63. Hatanaka,M. and Nam,S.H.
    Identification of HTLV-I gag protease and its sequential processing of the gag gene product
    J Cell Biochem (1989) 40, 15-30. PubMed  Europe PubMed DOI
  64. Hatfield,D., Feng,Y.X., Lee,B.J., Rein,A., Levin,J.G. and Oroszlan,S.
    Chromatographic analysis of the aminoacyl-tRNAs which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV
    Virology (1989) 173, 736-742. PubMed  Europe PubMed DOI
    65. 1988
  65. Nam,S.H., Kidokoro,M., Shida,H. and Hatanaka,M.
    Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease
    J Virol (1988) 62, 3718-3728. PubMed  Europe PubMed  PMC  EPMC
    66. 1987
  66. [YEAR:15-10-1987]Katoh,I., Yasunaga,T., Ikawa,Y. and Yoshinaka,Y.
    Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor
    Nature (15-10-1987) 329, 654-656. PubMed  Europe PubMed DOI  I
    67. 1986
  67. Inoue,J., Watanabe,T., Sato,M., Oda,A., Toyoshima,K., Yoshida,M. and Seiki,M.
    Nucleotide sequence of the protease-coding region in an infectious DNA of simian retrovirus (STLV) of the HTLV-I family
    Virology (1986) 150, 187-195. PubMed  Europe PubMed
  68. Nam,S.H. and Hatanaka,M.
    Identification of a protease gene of human T-cell leukemia virus type I (HTLV-I) and its structural comparison
    Biochem Biophys Res Commun (1986) 139, 129-135. PubMed  Europe PubMed  I
    69. 1985
  69. Ratner,L., Hasetine,W., Patarca,R., Livak,K.J., Starcich,B., Josephs,S.F., Doran,E.R., Rafalski,J.A., Whitehorn,E.A., Baumeister,K., Ivanoff,L., Petteway,S.R., Jr., Pearson,M.L., Lautenberger,J.A., Papas,T.S., Ghrayeb,J., Chang,N.T., Gallo,R.C. and Wong-Staal,F.
    Complete nucleotide sequence of the AIDS virus, HTLV-III
    Nature (1985) 313, 277-284. PubMed  Europe PubMed
  70. Shimotohno,K., Takahashi,Y., Shimizu,N., Gojobori,T., Golde,D.W., Chen,I.S., Miwa,M. and Sugimura,T.
    Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene
    Proc Natl Acad Sci U S A (1985) 82, 3101-3105. PubMed  Europe PubMed  PMC  EPMC
    71. 1984
  71. [YEAR:3-12-1984]Sagata,N., Yasunaga,T. and Ikawa,Y.
    Identification of a potential protease-coding gene in the genomes of bovine leukemia and human T-cell leukemia viruses
    FEBS Lett (3-12-1984) 178, 79-82. PubMed  Europe PubMed DOI
    72. 1983
  72. Seiki,M., Hattori,S., Hirayama,Y. and Yoshida,M.
    Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
    Proc Natl Acad Sci U S A (1983) 80, 3618-3622. PubMed  Europe PubMed  PMC  EPMC

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use